Sign in

CIK 0001321834 · Non-accelerated filer<br>Smaller reporting company

Q/C TECHNOLOGIES, INC.

Sign in to watch
Ticker
QCLS
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
856-848-8698
Business address
1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
Former names
Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
  1. EFFECT Other Notice of Effectiveness
  2. CORRESP Other Correspondence Between Filers and SEC Staff
  3. S-3 Offering Registration Statement
  4. 4 Insider Changes in Ownership
  5. 3 Insider Initial Statement of Ownership
  6. UPLOAD Other SEC-generated Letter
  7. 8-K Event Material agreement · Executive or director change · Other events
  8. DRS Other Draft Registration Statement
  9. 8-K Event Material agreement · Unregistered share sale · Other events
  10. 424B3 Offering Prospectus
  11. EFFECT Other Notice of Effectiveness
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. 10-Q Report Quarterly Report
  14. 4 Insider Changes in Ownership
  15. SCHEDULE 13D/A Stake Beneficial Ownership Report
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 2 of 31 · 604 filings